Bioretec Corrects Stock Option Plan Details
Bioretec Ltd has corrected previously released information regarding a new stock option plan approved by its Board of Directors on June 1, 2026. The correction pertains to the quantities of options designated as 2026A and 2026B.
Bioretec Ltd has issued a correction to its announcement dated June 1, 2026, concerning a new stock option plan. The company's Board of Directors made decisions regarding the plan, but the initial release contained an error in the number of stock options marked as '2026A' and '2026B'.
The corrected figures indicate that there are now 97,584,430 stock options of the '2026A' designation. The previously reported incorrect number was 96,059,674. The quantity for '2026B' options has also been amended. The correct number is now 86,911,133, which was incorrectly reported as the same figure previously. This correction was issued on July 7, 2026, at 6:55 p.m. EEST.
The original announcement had stated incorrect quantities of 96,059,674 for '2026A' options and 86,911,133 for '2026B' options. The company has not provided further details on the cause of the discrepancy but clarified that the information has been rectified.
The new stock option plan was approved by the board decision in early June. Bioretec has not commented on the specific terms of the plan or its broader implications for management incentives.